| Name | 5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carboxylic acid |
|---|---|
| Synonyms |
4-Thiazolecarboxylic acid, 5-(4-fluorophenyl)-2-methyl-
5-(4-Fluorophenyl)-2-methyl-1,3-thiazole-4-carboxylic acid |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 376.5±27.0 °C at 760 mmHg |
| Molecular Formula | C11H8FNO2S |
| Molecular Weight | 237.250 |
| Flash Point | 181.5±23.7 °C |
| Exact Mass | 237.025970 |
| PSA | 78.43000 |
| LogP | 1.81 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.610 |
| HS Code | 2934100090 |
|---|
|
~93%
433283-22-8 |
| Literature: Actelion Pharmaceuticals Ltd. Patent: US2010/222600 A1, 2010 ; Location in patent: Page/Page column 23 ; US 20100222600 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |